TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›VENU
VENU logo

VENU

Venu Holding Corp

Next earnings Aug 17, 2026 · consensus $-0.30 EPS, $4.90M rev

Last earnings -3.1% on 2026-05-15

Avoid
$2.18
▼ -10.66%
$2.18▼ -80.74%
over 1Y
L $2.18H $18.10
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-10.7%
1W-28.5%
1M-40.8%
3M-34.9%
YTD-72.7%
1Y-80.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
F
Valuation
Fair value
Filings
Flagged
Avoid
Conviction
Horizon
Long (>12mo)
Street · 7 analysts
Buy

Cash-burning amphitheater builder with flat revenue, a $44M loss, going-concern history and relentless dilution — a speculation, not an investment.

Revenue $17.9M · FY2025

Venu is a pre-scale hospitality/entertainment developer building luxury amphitheater campuses, and the numbers show a company still deep in its capital-consumption phase with no proof the model works at scale. Revenue was $17.9M in FY2025 — essentially flat (+0.4%) after jumping from $12.6M to $17.8M the year prior — so the top line stalled at the exact moment the loss exploded. Net loss widened to -$44.1M (net margin -246%) from -$30.3M, operating income was -$46.1M, and the accumulated deficit deepened to -$91.5M. When a buildout story's revenue flatlines while losses accelerate, the burden of proof is entirely on management's forward plan, and there is no track record here to underwrite it: the company has lost money every year of its existence (2023, 2024, 2025).

The balance sheet is the story of that buildout, and it cuts both ways. Total assets doubled to $371M on $142M of capex, but that was funded by a 261% surge in liabilities (to $172M), a 301% jump in long-term debt (to $56.6M), and a 60% increase in the share count — heavy leverage plus heavy dilution simultaneously. Working capital is already negative: current liabilities of $57.4M exceed current assets of $44.3M. Critically, the 10-K itself states these conditions 'raised substantial doubt about the Company's ability to continue as a going concern,' with management claiming that doubt is only 'alleviated' by a plan that explicitly depends on 'additional capital raising and debt financing,' the January 2026 Series B Preferred issuance, and the March 2026 public offering. The Risk Factors are blunt that equity raises could cause 'significant dilution' and grant new holders rights 'superior to those of existing shareholders' — a direct threat to the $2.18 common holder.

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 12:22 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Is VENU a buy? The one-page verdict, explained →

Financials · annual, by fiscal year

Line itemFY23FY24FY25
Revenue$12.6M$17.8M$17.9M
Gross profit———
Operating income-$11.1M-$27.4M-$46.1M
Net income-$10.5M-$30.3M-$44.1M
Diluted EPS—-$0.86-$1.10
Net margin-83.5%-170.1%-246.4%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$194M
EV / EBITDA—
EV / Sales10.9
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-35.0%
FCF yield-106.2%

Quality & risk

ROIC (est.)-19.1%
Free cash flow-$134M
Total debt$68.1M
Net cash—
Altman Z-Score-0.31 distress
Piotroski F-Score3/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+60.1%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 8-K Material agreement2026-06-12

    Signed new material definitive agreement (likely venue/financing); terms not quantified

  2. 8-K Agreement terminated2026-06-11

    New agreement + unregistered share sale (dilution); one prior agreement terminated

  3. 8-K Earnings results2026-05-15

    Q1 2026: still deeply loss-making as new venues ramp; liquidity tight

  4. 10-Q Quarterly report2026-05-15

    Q1 2026: still deeply loss-making as new venues ramp; liquidity tight

  5. 8-K Material agreement2026-05-13

    Entered another material agreement, likely venue development or funding

  6. 8-K Earnings results2026-04-02

    Announced FY2025 results: net loss widened to ~$44M on flat revenue

  7. 10-K Annual report2026-03-31

    FY2025 net loss -$44M, going-concern doubt (mgmt deems alleviated), assets 2x

  8. 8-K Material agreement2026-03-11

    Completed March 2026 public offering; raised capital but dilutive

  9. S-3 Shelf registration (potential raise)2025-12-01

    Filed shelf registration enabling future raises — dilution overhang

Recent filings

all on EDGAR ↗
4Period ending 2026-05-262026-06-22open ↗8-KPeriod ending 2026-06-122026-06-12open ↗424B5Filing2026-06-12open ↗8-KPeriod ending 2026-06-052026-06-11open ↗4Period ending 2026-06-052026-06-09open ↗SCHEDULE 13GFiling2026-05-15open ↗8-KPeriod ending 2026-05-152026-05-15open ↗10-QPeriod ending 2026-03-312026-05-15open ↗8-KPeriod ending 2026-05-082026-05-13open ↗4Period ending 2026-05-072026-05-07open ↗8-KPeriod ending 2026-03-312026-04-02open ↗10-KPeriod ending 2025-12-312026-03-31open ↗

Quality score

F
ValueGrowthProfitHealthMom.
ValueC
GrowthF
ProfitabilityF
Financial healthC+
MomentumF
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
2.1852-week18.10
Revenue
$17.9M
+0.4% YoY
Net margin
-246.4%
ROE
-35.9%
P/E
—

SEC fundamentals · FY 2025

'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$17.9M+0.4%
Net income-$44.1M-45.3%
Operating income-$46.1M-68.5%
Diluted EPS-$1.10-27.9%
Total assets$371M+107.7%
Total liabilities$172M+260.7%
Stockholders' equity$123M+28.2%
Op.: -257.8%L/E: 1.40x

Frequently asked

Is Venu Holding Corp (VENU) a buy?
VENU currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Cash-burning amphitheater builder with flat revenue, a $44M loss, going-concern history and relentless dilution — a speculation, not an investment.
What is Venu Holding Corp's quality score?
VENU scores 36.48497267759563/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001770501, latest 10-Q filed 2026-05-15) · EODHD · Proprietary analysis · as of 7/3/2026, 4:22:44 PM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 1 open-market buy · 0 sales

2026-05-26
Finke Thomas M
Director
Buy15.0K @ $3.74$56.1K
2026-03-10
ROTH JAY W
CEO & Chairman
Buy62.5K @ $4.00$250K
2026-02-20
ROTH JAY W
CEO & Chairman
Buy4.00K @ $5.23$20.9K
2026-01-30
ROTH JAY W
CEO & Chairman
Buy5.00K @ $5.55$27.8K

Earnings history

beat/miss · move
2026-05-15Miss -18.5% est▼ -3.11%8-K ↗
2026-04-02Miss -18.5% est▼ -1.47%8-K ↗
2026-01-27Miss -22.5% est▼ -3.27%8-K ↗
2025-11-17Beat +41.2% est▼ -21.45%8-K ↗
2025-08-15Miss -5.0% est▼ -0.06%8-K ↗
2025-05-16—▲ +12.61%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Venu Holding Corp (VENU) Q1 2026 Earnings Call Highlights: Strategic Partnerships and ...Bullish
finance.yahoo.com· 2026-05-15
Restaurant check: The gas price sell-off may be overdoneBullish
seekingalpha.com· 2026-04-03
Is Pepsi Football Nation And New Venue Deals Reshaping the Investment Case For PepsiCo (PEP)?Bullish
finance.yahoo.com· 2026-04-01
Venu Q4 Earnings Call HighlightsBullish
finance.yahoo.com· 2026-04-01
VENU Names Sarah Rothschild as Senior Vice President of Strategic Finance and Investor RelationsBullish
finance.yahoo.com· 2026-03-30
Quant snapshot: J. Jill, AngioDynamics leads strong buys as INmune Bio, Terrestrial Energy lagBullish
seekingalpha.com· 2026-03-29

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score36 vs 67
Revenue growth0.4% vs 7.5%
Net margin-246.4% vs 10.0%
Return on equity-35.9% vs 12.0%
P/E— vs 26.2